🇦🇹 Austria Country × Condition
ovarian cancer Clinical Trials in Austria
Active clinical trials for ovarian cancer with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT06973161
Recruiting
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Enrollment
105 pts
Country
🇦🇹 Austria
AstraZeneca
View Trial → NCT06819007 Phase 3
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Enrollment
582 pts
Country
🇦🇹 Austria
Daiichi Sankyo
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in Austria?
There are currently 2 active clinical trials for ovarian cancer with sites in Austria, of which 2 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in Austria?
To join a ovarian cancer clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in Austria?
Active ovarian cancer trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.